It has been demonstrated that the expression levels of the human CRY1, CRY2, PER1, PER2, PER3, and BMAL1 genes were down-regulated in both the chronic phase and blast crisis in chronic myeloid leukemia (CML) [43]. This evidence concerns the gene PER1 and chronic myelogenous leukemia, BCR-ABL1 positive.